About AB-Biotics
AB-Biotics is a company based in Barcelona (Spain) founded in 2004 by Miquel Angel Bonachera was acquired by Kaneka in September 2019.. AB-Biotics offers products and services including Probiotic Strains, Probiotic Formulas, and Market-ready Probiotic Products. AB-Biotics operates in a competitive market with competitors including Denali Therapeutics, Novozymes, Poseida Therapeutics, Castle Biosciences and Juno Therapeutics, among others.
- Headquarter Barcelona, Spain
- Founders Miquel Angel Bonachera
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ab-Biotics, Sa
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AB-Biotics
AB-Biotics offers a comprehensive portfolio of products and services, including Probiotic Strains, Probiotic Formulas, and Market-ready Probiotic Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Unique strains with mechanisms of action for targeted health applications.
Scientifically-documented solutions for various therapeutic health needs.
Premium formulations adapted for functional food and pharmaceutical markets.
Unlock access to complete
Funding Insights of AB-Biotics
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(19 Dec 2012)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Post-IPO - AB-Biotics | Valuation |
investors |
|
| Mar, 2018 | Amount | Grant - AB-Biotics | Valuation |
investors |
|
| Oct, 2017 | Amount | Grant - AB-Biotics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AB-Biotics
AB-Biotics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Almirall, European Union and Kaneka. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Inveready is recognized as a leading Spanish financial services firm.
|
Founded Year | Domain | Location | |
|
Venture capital investment fund
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AB-Biotics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AB-Biotics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ab-Biotics Comparisons
Competitors of AB-Biotics
AB-Biotics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Novozymes, Poseida Therapeutics, Castle Biosciences and Juno Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ab-Biotics
Frequently Asked Questions about AB-Biotics
When was AB-Biotics founded?
AB-Biotics was founded in 2004 and raised its 1st funding round 8 years after it was founded.
Where is AB-Biotics located?
AB-Biotics is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Who is the current CEO of AB-Biotics?
Miquel Angel Bonachera is the current CEO of AB-Biotics. They have also founded this company.
What does AB-Biotics do?
AB-Biotics was founded in 2004 in Barcelona, Spain, focusing on the biotechnology and pharmaceutical sectors. Probiotic drugs are developed primarily for dental disorders, with a portfolio of 21 products spanning categories such as cardiometabolic health, oral care, pediatrics, gastrointestinal health, gynecology, urology, dermatology, and immunology. Drugs for central nervous system disorders are also created. Nutraceuticals are provided for pharmaceutical and food industries, alongside services in genetic analyses for pharmacogenetic studies.
Who are the top competitors of AB-Biotics?
AB-Biotics's top competitors include Juno Therapeutics, Novozymes and Poseida Therapeutics.
What products or services does AB-Biotics offer?
AB-Biotics offers Probiotic Strains, Probiotic Formulas, and Market-ready Probiotic Products.
Who are AB-Biotics's investors?
AB-Biotics has 6 investors. Key investors include Almirall, European Union, Kaneka, EIC Fund, and Inveready.